Tuesday, December 15, 2015

Valeant: An Accounting Pioneer, Too

Embattled drugmaker Valeant Pharmaceuticals’ books look very different from those of its peers. Here are three ways its accounting is unusual.

from WSJ.com: US Business http://ift.tt/1JaDSr2
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)